R386-702-2. Definitions

(1) "Acute care hospital" means a hospital that: (a) offers emergency care 24 hours a day; and (b) has at least one physician on staff or the medical roster who is available to the emergency care area within 30 minutes of a request. (2) "Assisted living facility" means the same as defined in Section 26B-2-201. (3) "Bioterrorism" means the same as defined in Section 26B-7-301. (4) "Blood and plasma center" means: (a) a blood bank; (b) a blood storage facility; (c) a plasma center; (d) a hospital; (e) any facility that collects blood or blood products; or (f) any facility that provides blood services. (5) "Care facility" means a facility licensed through the department, including any: (a) adult day care facility; (b) adult foster care facility; (c) crisis respite facility; (d) domestic violence shelter and treatment center; (e) foster care home; (f) mental health treatment facility; (g) residential treatment and day treatment facility for persons with disabilities; (h) substance abuse treatment facility; or (i) youth treatment facility. (6) "Carrier" means the same as defined in Section 26B-7-201. (7) "Case" means any person, living or deceased, identified as having a communicable disease, condition, or syndrome that meets criteria for being reportable under this rule or that is otherwise under public health investigation. (8) "Category one laboratory" means a facility that conducts any type of CLIA-certified testing, which identifies reportable conditions listed in Sections R380-702-4, R380-702-6, and R380-702-7. (9) "Category two laboratory" means a facility that only conducts CLIA-waived testing, which identifies reportable conditions listed in Sections R380-702-4, R380-702-6, and R380-702-7. (10) "Child care" means the same as defined in Section 26B-2-401. (11) "Clinic" means any facility where a health care provider practices. (12) "Clinical material" means: (a) an isolate containing an organism listed in Subsections R386-702-6(3) and R386-702-6(4); or (b) if an isolate is not available, material containing the organism, in the following order of preference: (i) a patient specimen; (ii) nucleic acid; or (iii) other laboratory material. (13) "Communicable disease" means the same as defined in Section 26B-7-201. (14) "Condition" means an abnormal state of health that may interfere with a person's regular feelings of wellbeing. (15) "Contact" means the same as defined in Section 26B-7-201. (16) "Correctional facility" means a facility that forcibly confines an individual under the authority of the government, including any: (a) detention center; (b) jail; (c) juvenile detention center; or (d) prison. (17) "Department" means the Department of Health and Human Services. (18) "Diagnostic facility" means the facility where a case or suspect case was seen and evaluated by a health care provider. (19) "Dispensary" means an office in a hospital, industrial plant, school, or other organization that dispenses medication or medical supplies. (20) "Electronic case reporting" or "eCR" means the transmission of clinical, diagnostic, laboratory, and treatment-related data from a reporting entity to the department using the HL7 CDA R2 Implementation Guide: Public Health Case Report, the Electronic Initial Case Report (eICR) Release 3.1.1 -- US Realm or higher. (21) "Electronic laboratory reporting" or "ELR" means the transmission of laboratory or health-related data from a reporting entity to the department using HL7 ORU-R01 2.5.1, LOINC, or SNOMED standard message structure and vocabulary. (22) "Electronic reporting" means the transmission of laboratory or health-related data in a structured, computer-readable, department-approved format that reflects comparable content to HL7 messaging. (23) "Encounter" means a documented interaction between a patient and a health care provider when medical services are provided. (24) "Epidemic" means the same as defined in Section 26B-7-201. (25) "Event" means any instance of a communicable disease, condition, epidemic, laboratory result, outbreak, syndrome, or other public health hazard that is of concern to the public and meets criteria for being reportable under Section R386-702-4. (26) "Good Samaritan" means a person who gives reasonable aid to a stranger in grave physical distress. (27) "Health care facility" means the same as defined in Section 78B-3-403. (28) "Health care provider" means the same as defined in Section 78B-3-403. (29) "Infection" means the same as defined in Section 26B-7-201. (30) "Invasive" means infection occurring in any part of the body where organisms are not normally present, including the bloodstream, meninges, or an organ. (31) "Laboratory" means any facility that receives, refers, or analyzes clinical specimens. (32) "Local health department" means the same as defined in Section R386-80-2. (33) "Mental health facility" means the same as defined in Section 26B-5-301. (34) "Normally sterile site" means a part of the body where organisms are not normally present, including the bloodstream, meninges, or an organ. (35) "Office" means the Office of Communicable Diseases under the Department of Health and Human Services. (36) "Outbreak" means: (a) the increased occurrence of any communicable disease, health condition, or syndrome in a community, institution, or region; or (b) two or more cases of a communicable disease, health condition, or syndrome in persons with a common exposure. (37) "Public health hazard" means the presence of an infectious organism or condition in the environment that endangers the health of a specified population. (38) "SARS-CoV-2 NAAT" means any SARS-CoV-2 Nucleic Acid Amplification Test (NAAT) conducted in a facility certified under CLIA to perform a moderate- or high-complexity test. (39) "School" means the same as defined in Section 26B-7-201. (40) "Suspect case" means any person, living or deceased, who: (a) has not yet been proven to meet the necessary criteria to be classified a case; and (b) the department, a local health department, or a reporting entity has reason to believe might be a case. (41) "Syndrome" means a set of signs or symptoms that often occur together. (42) "Syndromic surveillance" means the systematic, ongoing collection and transmission of health data from the point of care, for public health purposes, to the department using HL7 version 2.5.1 or higher. (43) "UPHL" means the Utah Public Health Laboratory.